Transfusion-associated graft-versus-host disease:Who is at Risk?

Anderson, 1990, Transfusion-associated graft-versus-host disease, N Engl J Med, 323, 315, 10.1056/NEJM199002013220507 Anderson, 1991, Variation in transfusion practice: implications for the prevention of transfusion-associated graft versus host disease, Blood, 77, 2096, 10.1182/blood.V77.10.2096.2096 Thaler, 1989, The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open heart surgery, N Engl J Med, 321, :25, 10.1056/NEJM198907063210105 Ito, 1988, Change of HLA phenotype in post operative erythroderma, Lancet, i, 413, 10.1016/S0140-6736(88)91204-4 Juji, 1989, Post transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery, N Engl J Med, 321, 56, 10.1056/NEJM198907063210116 Kruskall, 1990, HLA-homozygous donors and transfusion-associated graft-versus-host disease, N Engl J Med, 322, 1005 Ferrara, 1991, Graft versus host disease, N Engl J Med, 324, 667, 10.1056/NEJM199103073241005 Leitman, 1985, Irradiation of blood products: indications and guidelines, Transfusion, 25, 293, 10.1046/j.1537-2995.1985.25485273804.x Drobyski, 1989, Third party mediated graft rejection and graft-versus-host disease after T cell depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism, Blood, 74, 2285, 10.1182/blood.V74.6.2285.2285 Deeg, 1989, Prevention of transfusion-induced graftversus-host disease in dogs by ultraviolet irradiation, Blood, 74, 2592, 10.1182/blood.V74.7.2592.2592